Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Hepatol. Feb 27, 2023; 15(2): 255-264
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.255
Table 2 Descriptive analysis of donor extended criteria over the years, n (%)
Variable (year)
2017
2018
2019
2020
Total
Macroscopic assessment of steatosis in the organ5 (1.99)0 (0.00)3 (0.66)4 (0.89)12 (0.74)
Age > 65 yr35 (14.00)69 (14.90)67 (14.73)52 (11.56)223 (13.78)
ICU > 7 d81 (32.27)143 (30.89)145 (31.87)153 (34.00)522 (32.24)
BMI > 30 kg/m261 (24.30)82 (17.71)90 (19.78)80 (17.78)313 (19.33)
Serum sodium > 165 mmol/L39 (15.54)82 (17.71)73 (16.04)64 (14.22)258 (15.94)
AST > 90 U/L72 (28.69)172 (37.23)184 (40.44)187 (41.65)615 (38.03)
ALT > 105 U/L54 (21.51)108 (23.38)111 (24.45)93 (20.71)366 (22.65)
Total bilirubin > 3 mg/dL6 (2.39)13 (2.83)25 (5.51)18 (4.01)62 (3.84)
Number of variables to classify a donor as an extended criteria donor
  054 (21.51)96 (20.73)106 (23.30)95 (21.11)351 (21.68)
  194 (37.45)159 (34.34)122 (26.81)158 (35.11)533 (32.92)
  261 (24.30)133 (28.73)133 (29.23)119 (26.44)446 (27.55)
  332 (12.75)58 (12.53)68 (14.95)59 (13.11)217 (13.40)
  49 (3.59)15 (3.24)24 (5.27)17 (3.78)65 (4.01)
  51 (0.40)2 (0.43)2 (0.44)2 (0.44)7 (0.43)